Recombinant Human Bone Morphogenetic Protein, or rhBMP, is an osteoinductive protein produced by recombinant DNA technology. It has been found to be an efficient product in assisting with bone re-growth and the osseointegration of implants. The use of recombinant technology and tissue engineering combines the most recent biotechnology techniques with the body’s natural response to injured tissues. This process boosts the body’s ability to heal following an implant procedure by increasing the rate of osseointegration. The technology used in rhBMP often consists of combining mesenchymal stem cells with added attachment and form properties to promote growth factor. Despite the advantages of recombinant human bone morphogenetic proteins, oral surgeons must still perform a detailed examination of the patient’s oral anatomy to determine if the use of rhBMP will be effective. This is due in part to the necessity of choosing the correct bone grafting technique to ensure the highest possibility for implant success.